Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle
breakthrough, chemotherapy, ESMO, lung, Merck, Oncology, pembro, pembrolizumab, small cell, treatment
0 Comment
Merck unveils impressive data on Keytruda, trumping BMS’ Opdivo